Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome

Therapeutic Advances in Endocrinology and Metabolism
Huda AlalamiStephen L Atkin

Abstract

Women with polycystic ovary syndrome (PCOS) have an adverse metabolic profile with an increased risk of prediabetes and type 2 diabetes (T2DM); however, it is unclear if PCOS is associated with increased cardiovascular events in later years independent of the presence of T2DM. Many therapies have been used to treat the differing facets of PCOS, including those for menstrual irregularity, hirsutism, acne and anovulatory infertility. The aim of this review was to evaluate the cardiovascular profiles associated with the medications used in the management of PCOS and evaluate whether they have cardiovascular benefit, detriment or are neutral. The medications reviewed include oral contraceptive pills, antiandrogens, clomiphene and drugs specifically used in diabetes therapy; metformin, glitazones, dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 receptor agonists. This review concludes that therapies that are used to treat these patients appear not to add to the cardiovascular risk and that there is no evidence that any interventional medical therapy may prevent the onset of diabetes in patients with PCOS, though in the case of metformin, this agent may be beneficial in preventing development of gestational diabetes.

References

Jun 1, 1992·Diabetes Care·C J Bailey
Nov 1, 1996·Human Reproduction Update·R P Dickey, D E Holtkamp
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·E Diamanti-KandarakisA J Duleba
Oct 22, 1998·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·B Ahrén
May 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·C Day
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Mar 29, 2002·Diabetes/metabolism Research and Reviews·Hans Hauner
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Caren G SolomonJoann E Manson
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Evanthia Diamanti-KandarakisJohn E Nestler
Mar 25, 2005·The New England Journal of Medicine·David A Ehrmann
Feb 25, 2006·Human Reproduction·Evanthia Diamanti-KandarakisDimitrios Panidis
Dec 13, 2006·Metabolism: Clinical and Experimental·Evanthia Diamanti-KandarakisDimitrios Panidis
Feb 9, 2007·The New England Journal of Medicine·Richard S LegroUNKNOWN Cooperative Multicenter Reproductive Medicine Network
Aug 28, 2007·Lancet·Robert J NormanTheresa E Hickey
May 8, 2008·The Journal of Clinical Endocrinology and Metabolism·Karen Elkind-HirschRajat Bhushan
Jul 22, 2008·Diabetes & Metabolism·J-F GautierJ Girard
Sep 13, 2008·Journal of Endocrinological Investigation·B VrtovecB Radovancevic
Mar 13, 2009·Human Reproduction Update·Lisa Moran, Helena Teede
Aug 15, 2009·BMJ : British Medical Journal·Øjvind LidegaardCarsten Agger
Jun 10, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Dorte Glintborg, Marianne Andersen
Dec 16, 2010·European Journal of Endocrinology·Katica Bajuk StudenJanez Prezelj
Nov 19, 2011·European Journal of Endocrinology·T Sathyapalan, S L Atkin
Jun 12, 2012·Lancet·Adam G TabákMika Kivimäki
Jul 26, 2012·Endocrine Reviews·Harpal S RandevaHendrik Lehnert
Dec 5, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Steven T BirdJoseph A C Delaney
Jan 29, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·M FerwanaM H Murad
Apr 30, 2013·Steroids·Daniel A Dumesic, Rogerio A Lobo
Oct 2, 2013·The Journal of Clinical Endocrinology and Metabolism·A E JohamH J Teede
Oct 24, 2013·The Journal of Clinical Endocrinology and Metabolism·Richard S LegroUNKNOWN Endocrine Society
Feb 21, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Donatella CasertaMassimo Moscarini
Jul 3, 2015·The New England Journal of Medicine·Xavier Pi-SunyerUNKNOWN SCALE Obesity and Prediabetes NN8022-1839 Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.